U.S. Newswire - Court Takes Matter of Wyeth’s Motion for Preliminary Injunction Under Advisement; Obtains Agreement from Teva and Sun to Delay Any Potential Launch of Generic…
To: LEGAL AFFAIRS EDITORS
Contact: Media, Doug Petkus, 1-973-660-5218, or Gwen Fisher, 1-
484-865-5160; or Investors, Justin Victoria, 1-973-660-5340, all of
Wyeth
Related Results
AHP Posts Flat Earnings But Gears Up for Growth.
Court Takes Matter of Wyeth’s Motion for Preliminary Injunction Under Advisem…
West Nile Virus infection in a renal transplant recipient
Prevacid held slight lead in proton pump inhibitor sales to retailers for 200…
Colorado Medicaid instituted a limit of eight prescriptions per patient at an…
MADISON, N.J., July 31 /PRNewswire-FirstCall/ — Wyeth (NYSE:
WYE), and its business partner Nycomed, announced today that the
United States District Court for the District of New Jersey has taken
the matter of Wyeth and Nycomed’s motion for a preliminary injunction
against Teva Pharmaceuticals USA, Inc. and Sun Pharmaceuticals Inc.
in regard to a potential launch of a generic version of Protonix(R)
(pantoprazole sodium) under …
Read the rest of this article with a Free Trial at HighBeam Research.
